HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adenosquamous carcinoma of the uterine cervix--adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report.

Abstract
Adenosquamous carcinoma of the uterine cervix is a rare mixture of malignant glandular and squamous epithelial elements. We present a case of a 56-year-old woman with Stage IV cervical carcinoma treated with paclitaxel and carboplatin chemotherapy after cytoreductive surgery. Solitary liver metastases were treated by ultrasound guided percutaneous sclerotherapy with 95% ethanol. For ten months the patient showed an objective response to the treatment with a good quality of life during that time. A year after the first, the second cytoreductive operation was performed and chemotherapy (paclitaxel, carboplatin, and epirubicin) followed. The patient died 20 months after establishing the diagnosis. Paclitaxel in combination with carboplatin as adjuvant chemotherapeutic treatment could be another promising agent for patients with advanced metastatic cervical adenocarcinoma.
AuthorsV Radić, V Kukura, S Ciglar
JournalEuropean journal of gynaecological oncology (Eur J Gynaecol Oncol) Vol. 26 Issue 4 Pg. 449-50 ( 2005) ISSN: 0392-2936 [Print] Singapore
PMID16122201 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Sclerosing Solutions
  • Ethanol
  • Epirubicin
  • Carboplatin
  • Paclitaxel
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carboplatin (administration & dosage)
  • Carcinoma, Adenosquamous (secondary, therapy)
  • Epirubicin (administration & dosage)
  • Ethanol (administration & dosage)
  • Fatal Outcome
  • Female
  • Gynecologic Surgical Procedures (methods)
  • Humans
  • Injections, Intralesional
  • Liver Neoplasms (secondary, therapy)
  • Middle Aged
  • Neoplasm Staging
  • Paclitaxel (administration & dosage)
  • Sclerosing Solutions (administration & dosage)
  • Sclerotherapy (methods)
  • Treatment Outcome
  • Uterine Cervical Neoplasms (pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: